Jacob H. C.
- Country
- Denmark
- Department
- Hematology
Research Overview
- Phase 1 Study of JNJ-80948543, a T-cell Redirecting Antibody, in Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Patients
- Phase 1 Study of JNJ-95804306 in Relapsed or Refractory AML, CLL, Higher‑Risk MDS, and SLL
- Evaluation of Epcoritamab in Combination with Chemotherapeutic Agents in B-cell Non-Hodgkin Lymphoma: A Phase 1b/2 Open-Label Study
Data & Insights
Has run more than one trial at 130 of 329 partner sites.
Specializations
Hematologic Malignancies
Jacob Haaber Christensen is involved in clinical research across a broad spectrum of hematologic cancers, with particular attention to acute lymphoblastic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia, multiple myeloma, and diverse forms of lymphoma.
- Acute leukemias and relapsed blood cancers
- B-cell and T-cell lymphoma
- Plasma cell disorders
His trial portfolio also includes light chain amyloidosis, myelofibrosis, and essential thrombocythemia, reflecting a strong therapeutic focus on advanced blood disorders and targeted treatment strategies.
Cardiovascular Disease
His research activity extends to cardiovascular disease prevention and treatment, including atherosclerotic cardiovascular disease, acute coronary syndrome, myocardial infarction, atrial fibrillation, and heart failure.
- Coronary artery disease and secondary prevention
- Arrhythmia and thromboembolic risk
- Heart failure and structural heart disease
He is also engaged in studies of cardiac arrest, stroke prevention, dyslipidemia, and hypertrophic cardiomyopathy, supporting therapeutic innovation in high-risk cardiovascular care.
Autoimmune and Inflammatory Disorders
Jacob Haaber Christensen participates in trials addressing autoimmune disease and chronic inflammatory conditions, including Crohn’s disease, ulcerative colitis, rheumatoid arthritis, psoriatic arthritis, and systemic lupus erythematosus.
- Inflammatory bowel disease
- Systemic autoimmune rheumatic disease
- Immune-mediated neuropathy and urticaria
His interests also include myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, vasculitis, and Sjögren’s syndrome, with emphasis on immune-directed therapies.
Respiratory and Infectious Diseases
His clinical research landscape includes respiratory disease and infectious disease topics such as chronic obstructive pulmonary disease, asthma, bronchiectasis, idiopathic pulmonary fibrosis, and pulmonary sarcoidosis.
- Chronic and progressive lung disease
- Severe respiratory infection
- Mycobacterial and bacterial infection
He is additionally involved in studies of COVID-19, sepsis, bacteremia, and nontuberculous mycobacterial lung infection, indicating a therapeutic interest in complex pulmonary and antimicrobial care.
Oncology and Solid Tumors
Jacob Haaber Christensen also contributes to research in solid tumors, including breast cancer, colorectal cancer, lung cancer, ovarian cancer, bladder cancer, and prostate cancer.
- Gastrointestinal and genitourinary malignancies
- Thoracic and breast oncology
- Neuro-oncology and rare pediatric tumors
His portfolio further includes glioblastoma, medulloblastoma, diffuse glioma, and endometrial cancer, highlighting involvement in tumor-directed innovation across both adult and pediatric oncology.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.